Global Clinical Trial Disclosure and Data Transparency Conference

Learn about the latest requirements in clinical trial disclosure and data transparency, share best practices, and engage in in-depth discussions on hot topics.

Early Bird Rates Expire

DAYS

HOURS

MINUTES

SECONDS

Send Email 1.888.257.6457

返回 Agenda

Session 6: Results Reporting via CTIS and Policy 0070

Session Chair(s)

Merete Joergensen, MBA, MSc

Clinical Disclosure and Transparency Expert

Merete-J Consulting, Denmark

Session 6: Results Reporting via CTIS and Policy 0070

Speaker(s)

Speaker

Representative Invited

European Medicines Agency, Netherlands

Speaker

Representative Invited

European Medicines Agency, Netherlands

Examination of Risk-Based Clinical Document Anonymization Techniques and Related Processes

Representative Invited

Real Life Sciences, United States

Approach to Clinical Trial Transparency & Disclosure is Changing – EMA’s Policy 0070 is a Large Contributor

Representative Invited

Certara, Canada

Global Clinical Trial Disclosure and Data Transparency Conference

Session 6: Results Reporting via CTIS and Policy 0070

Session Chair(s)

Merete Joergensen, MBA, MSc

Speaker(s)

Speaker

Speaker

Examination of Risk-Based Clinical Document Anonymization Techniques and Related Processes

Approach to Clinical Trial Transparency & Disclosure is Changing – EMA’s Policy 0070 is a Large Contributor

获得信息并保持参与